Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARD-0403 in Testosterone Deficient Men
NCT00597051Phase 2Completed
- Sponsor
- Ardana
- Start
- Oct 2005
- Primary completion
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Itnogen in Hypogonadism (4 arms), sponsored by Ardana. Primary endpoint: Pharmacokinetic Profile. Started Oct 2005; status: completed.
02
Drugs
Itnogen
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT00597051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00597051.